Tango Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1.26M	27.7%	$6.98	+$8.76M
Sells	7	-3.28M	72.3%	$9.77	-$32M
Net	-5	-2.02M	-44.6%		-$23.3M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Third Rock Ventures IV, L.P.	10%+ Owner	$196M	-$24.8M	-11.2%	Sep 5, 2024
Boxer Capital, LLC	Other*	$139M	+$6.48M	+4.87%	Oct 13, 2023
EcoR1 Capital, LLC	10%+ Owner	$112M			Oct 13, 2023
BCTG Holdings, LLC	10%+ Owner	$58.6M			Aug 10, 2021
Barbara Weber	Chief Executive Officer, Director	$19.4M	-$115K	-0.59%	Feb 6, 2024
Daniella Beckman	Chief Financial Officer	$1.67M	-$46.9K	-2.73%	Feb 6, 2024
Third Rock Ventures VI, L.P.	Director	$1.63M			Aug 11, 2023
Adam Crystal	President, Research & Development	$1.51M	-$168K	-10%	Feb 6, 2024
Alan Huang	Chief Scientific Officer	$1.41M			Mar 1, 2023
MVA Investors, LLC	Other*	$944K	-$4.62M	-83%	Jun 28, 2024
Douglas Barry	General Counsel	$555K	-$35K	-5.92%	Feb 6, 2024
Braslyn Ltd.	10%+ Owner	$226K			Aug 10, 2021
John B. Ketchum	Director	$112K			Jun 5, 2024
Alexis Borisy	Director	$85.6K			Jun 5, 2024
Mace Rothenberg	Director	$81.1K			Jun 5, 2024
Malte Peters	Director	$81.1K			Jun 5, 2024
Lesley Ann Calhoun	Director	$45K	+$36K	+400%	Jun 5, 2024
Reid M. Huber	Director	$42K			Jun 6, 2023
Aaron Weitzman	Chief Medical Officer				Dec 1, 2022
Marc Rudoltz	Chief Medical Officer				Nov 1, 2021
Kanishka Pothula	Director				Nov 6, 2023
Davis Aaron I.	Other*				Sep 3, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.